Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Asia-Pacific Journal of Oncology Nursing|November 25, 2024
Relevance of surveillance manual for the early detection of immune checkpoint inhibitor-induced myocarditis: A case seriesTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2009
Long-term survivors of more than 5 years in advanced non-small cell lung cancerKyoichi Kaira, Toshiaki Takahashi, Haruyasu Murakami, et al.
Investigational New Drugs|July 2, 2016
Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumorsHidenori Mizugaki, Noboru Yamamoto, Haruyasu Murakami, et al.
Anticancer Research|August 27, 2011
Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancerKyoichi Kaira, Takehiro Okumura, Yasuhisa Ohde, et al.
General Thoracic and Cardiovascular Surgery|March 14, 2020
Conversion surgery for locally advanced malignant pleural mesotheliomaYukihiro Terada, Mitsuhiro Isaka, Haruyasu Murakami, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2020
Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancerBenjamin Besse, Pilar Garrido, Alexis B Cortot, et al.
Cancer Science|January 20, 2007
Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancerToru Itaya, Nobuyuki Yamaoto, Masahiko Ando, et al.
International Journal of Clinical Oncology|June 18, 2010
N-telopeptide of type I collagen is useful for monitoring therapeutic response in non-small cell lung cancer patients with bone metastasesRieko Kaira, Haruyasu Murakami, Kyoichi Kaira, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2010
[Evaluation of chemotherapy, especially combined therapy with Carboplatin Plus Etoposide(CE), in patients aged > or =80 years old with extensive-disease small-cell lung cancer]Akihiro Tamiya, Asuka Tsuya, Yukiko Nakamura, et al.
Anticancer Research|October 15, 2013
Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumorsKyoichi Kaira, Haruyasu Murakami, Masahiro Endo, et al.
Pageof 26